CLINICAL BURDEN AMONG PATIENTS WITH NEUROFIBROMATOSIS TYPE 1 (NF1) AND PLEXIFORM NEUROFIBROMA (PN) IN THE UNITED STATES (US)

被引：0
|
作者：
Yang, Xiaoqin [1 ]
Yoo, Hyun Kyoo [2 ]
Amin, Suvina [3 ]
Cheng, Wendy [4 ]
Sipsma, Heather [4 ]
Sundaresan, Sanjana [4 ]
Zhang, Lujia [4 ]
Duh, Mei Sheng [4 ]
机构：
[1] Merck & Co Inc, Rahway, NJ USA
[2] AstraZeneca, Cambridge, England
[3] AstraZeneca, Gaithersburg, MD USA
[4] Anal Grp Inc, Boston, MA USA
来源：
NEURO-ONCOLOGY | 2021年 / 23卷
关键词：
D O I：
10.1093/neuonc/noab090.167
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
RARE-06
引用
收藏
页码：41 / 42
页数：2
相关论文
共 50 条
  • [21] TRANSFORMATION OF CLINICAL CARE FOR PLEXIFORM NEUROFIBROMAS IN NEUROFIBROMATOSIS TYPE 1 (NF1) WITH THE ADVENT OF MEK INHIBITORS
    Viskochil, D.
    Gross, A.
    Dombi, E.
    Weiss, B.
    Widemann, B.
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2019, 179 (04) : 696 - 697
  • [22] PHASE I TRIAL OF SORAFENIB IN CHILDREN WITH NEUROFIBROMATOSIS TYPE I (NF1) AND INOPERABLE PLEXIFORM NEUROFIBROMAS (PN)
    Kim, A.
    Dombi, E.
    Tepas, K.
    Fox, E.
    Balis, F. M.
    Korf, B.
    Widemann, B. C.
    [J]. NEURO-ONCOLOGY, 2010, 12 (06) : II42 - II42
  • [23] Malignant peripheral nerve sheath tumour (MPNST) arising in plexiform neurofibroma in a neurofibromatosis type I (NF1) patient
    Sykaras, A.
    Gioti, E.
    Stavrinou, N.
    Dolkiras, P.
    Christofidis, K.
    Kouvidou, C.
    [J]. VIRCHOWS ARCHIV, 2021, 479 : S307 - S307
  • [24] Treatment of neurofibromatosis type 1 (NF1)-related plexiform neurofibromas PN) with cabozantinib (XL184): A Neurofibromatosis Clinical Trials Consortium Phase II trial
    Shih, Chie-Schin
    Blakeley, Jaishri
    Clapp, D. Wade
    Armstrong, Amy E.
    Wolters, Pam
    Dombi, Eva
    Cutter, Gary
    Ullrich, Nicole J.
    Allen, Jeffrey
    Packer, Roger
    Goldman, Stewart
    Gutmann, David H.
    Plotkin, Scott
    Rosser, Tena
    Robertson, Kent
    Widemann, Brigitte
    Rhodes, Steven
    Angus, Steven
    Johnson, Gary
    Korf, Bruce
    Fisher, Michael J.
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [25] Somatic loss of the NF1 gene in plexiform neurofibromas in neurofibromatosis type 1.
    Rasmussen, SA
    Colman, SD
    Abernathy, CR
    Muir, D
    Wallace, MR
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A80 - A80
  • [26] Congenital Craniofacial Plexiform Neurofibroma in Neurofibromatosis Type 1
    Cacchione, Antonella
    Carboni, Alessia
    Lodi, Mariachiara
    De Vito, Rita
    Carai, Andrea
    Marrazzo, Antonio
    Macchiaiolo, Marina
    Voicu, Ioan Paul
    Mastronuzzi, Angela
    Colafati, Giovanna Stefania
    [J]. DIAGNOSTICS, 2021, 11 (02)
  • [27] High Burden of Deep-Seated Plexiform Neurofibromas (PN) in Children with Neurofibromatosis 1 (NF1): Image-Defined Risk Factors
    Kelaidi, C.
    Petrikkos, L.
    Tzotzola, V. S.
    Antoniadi, K.
    Gavra, M.
    Stefanaki, K.
    Polychronopoulou, S.
    [J]. PEDIATRIC BLOOD & CANCER, 2019, 66 : S355 - S355
  • [28] Tumor burden evaluation in NF1 patients with plexiform neurofibromas in daily clinical practice
    Pratt, L.
    Helfer, D.
    Weizman, L.
    Shofty, B.
    Constantini, S.
    Joskowicz, L.
    Ben Bashat, D.
    Ben-Sira, L.
    [J]. ACTA NEUROCHIRURGICA, 2015, 157 (05) : 855 - 861
  • [29] Tumor burden evaluation in NF1 patients with plexiform neurofibromas in daily clinical practice
    L. Pratt
    D. Helfer
    L. Weizman
    B. Shofty
    S. Constantini
    L. Joskowicz
    D. Ben Bashat
    L. Ben-Sira
    [J]. Acta Neurochirurgica, 2015, 157 : 855 - 861
  • [30] Lymphomas in patients with neurofibromatosis type 1 (NF1): another malignancy in the NF1 syndrome?
    Fareez, Faiha
    Wang, Bill H.
    Brain, Ian
    Lu, Jian-Qiang
    [J]. PATHOLOGY, 2023, 55 (03) : 302 - 314
12345